611 related articles for article (PubMed ID: 17559359)
41. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Fischbach LA; van Zanten S; Dickason J
Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109
[TBL] [Abstract][Full Text] [Related]
43. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
[TBL] [Abstract][Full Text] [Related]
44. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
45. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
de Boer WA; van Etten RJ; Schade RW; Ouwehand ME; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 1996 Sep; 91(9):1778-82. PubMed ID: 8792697
[TBL] [Abstract][Full Text] [Related]
46. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Gisbert JP; Pajares JM
Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
[TBL] [Abstract][Full Text] [Related]
47. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
Cheon JH; Kim N; Lee DH; Kim JM; Kim JS; Jung HC; Song IS
Helicobacter; 2006 Feb; 11(1):46-51. PubMed ID: 16423089
[TBL] [Abstract][Full Text] [Related]
49. Eradication therapies for Helicobacter pylori.
Borody TJ; Shortis NP; Reyes E
J Gastroenterol; 1998; 33 Suppl 10():53-6. PubMed ID: 9840019
[TBL] [Abstract][Full Text] [Related]
50. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
[TBL] [Abstract][Full Text] [Related]
51. Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
Songür Y; Senol A; Balkarli A; Baştürk A; Cerçi S
Am J Med Sci; 2009 Jul; 338(1):50-3. PubMed ID: 19474657
[TBL] [Abstract][Full Text] [Related]
52. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
[TBL] [Abstract][Full Text] [Related]
54. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
55. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Gessner BD; Bruce MG; Parkinson AJ; Gold BD; Muth PT; Dunaway E; Baggett HC
Clin Infect Dis; 2005 Nov; 41(9):1261-8. PubMed ID: 16206100
[TBL] [Abstract][Full Text] [Related]
56. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Kuo CH; Hu HM; Kuo FC; Hsu PI; Chen A; Yu FJ; Tsai PY; Wu IC; Wang SW; Li CJ; Weng BC; Chang LL; Jan CM; Wang WM; Wu DC
J Antimicrob Chemother; 2009 May; 63(5):1017-24. PubMed ID: 19246508
[TBL] [Abstract][Full Text] [Related]
58. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
[TBL] [Abstract][Full Text] [Related]
59. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
60. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]